The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
By Mill Chart
Last update: Apr 11, 2024
Thursday's session: gap up and gap down stocks
Gap up stocks
| Ticker | Change | Comment |
|---|---|---|
| SMSI | 680.0% | Exciting news for SMITH MICRO SOFTWARE INC's (NASDAQ:SMSI) stock! It advanced 680.0% to $2.34 in today's session, accompanied by a notable 634.0% gap. The stock is trading 60.96% lower than 3 months ago. |
| RENT | 117.0% | RENT THE RUNWAY INC-A (NASDAQ:RENT) rose 117.0% to $16.09 with a gap of 18.55% during Thursday's session. Yesterday the company had a press release: Rent the Runway, Inc. Announces Fourth Quarter and Full Year 2023 Results. |
| RLYB | 66.87% | RALLYBIO CORP's (NASDAQ:RLYB) shares soared 66.87% to $2.72 during Thursday's session, accompanied by a significant gap of 61.68%. Yesterday the company had a press release: Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). |
| ALPN | 36.62% | ALPINE IMMUNE SCIENCES INC (NASDAQ:ALPN) rose 36.62% to $64.27 with a gap of 34.16% during Thursday's session. A press release (ALPN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alpine Immune Sciences, Inc. Is Fair to Shareholders) was released yesterday. |
| LXEH | 24.46% | LIXIANG EDUCATION HOLDIN-ADR's (NASDAQ:LXEH) shares surged 24.46% to $0.48 with a remarkable gap of 8.56%. In the last month the stock lost 92.04%. |
| ELVN | 23.81% | In today's session, ENLIVEN THERAPEUTICS INC's (NASDAQ:ELVN) stock experienced a notable rise of 23.81%, reaching $24.54 with a significant 13.49% gap. Shareholders saw the stock price going 55.45% higher in the past month. |
| CADL | 20.54% | CANDEL THERAPEUTICS INC's (NASDAQ:CADL) shares surged 20.54% to $6.15 with a remarkable gap of 8.86%. Earlier today the company had a press release: Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer. |
| CNXA | 20.3% | During Thursday's session, CONNEXA SPORTS TECHNOLOGIES's (NASDAQ:CNXA) stock price showed an impressive increase of 20.3%, reaching $0.95 with a substantial gap of 5.81%. In the last month the stock gained 237.0%. |
| HYMC | 16.64% | HYCROFT MINING HOLDING CORP's (NASDAQ:HYMC) shares surged 16.64% to $3.95 with a remarkable gap of 8.69%. Shareholders saw the stock price going 51.56% higher in the past month. |
| MNPR | 12.58% | Exciting news for MONOPAR THERAPEUTICS INC's (NASDAQ:MNPR) stock! It advanced 12.58% to $0.72 in today's session, accompanied by a substantial gap of 10.48%. A press release (Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients) was released yesterday. |
Our gap up stocks screener will show you the full list.
Top gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| APVO | -58.38% | APTEVO THERAPEUTICS INC's (NASDAQ:APVO) shares suffered a 58.38% decline to $1.0 during Thursday's session, accompanied by a 68.96% gap. Shareholders saw the stock price going 41.03% lower in the past month. |
| CLRO | -39.06% | CLEARONE INC's (NASDAQ:CLRO) shares suffered a 39.06% decline to $0.97 during Thursday's session, accompanied by a 42.63% gap. The stock is trading 22.82% lower than a month ago. |
| RCEL | -30.06% | During Thursday's session, AVITA MEDICAL INC's (NASDAQ:RCEL) stock price decreased by 30.06% to $10.1 with a significant 31.83% gap. Yesterday the company had a press release: AVITA Medical Updates Expected First Quarter 2024 Revenue. |
| LIFWW | -29.41% | MSP RECOVERY INC -27's (NASDAQ:LIFWW) stock price is declining with 29.41% to a price of $0.01 with a gap of 43.0%. In the last month the stock gained 118.0%. |
| AIH | -19.78% | AESTHETIC MEDICAL INTERN-ADR's (NASDAQ:AIH) shares experienced a 19.78% decline to $0.37 during Thursday's session, accompanied by a 23.63% gap. In the last 3 months the share price dropped with 23.98%. |
| GL | -15.65% | In today's session, GLOBE LIFE INC's (NYSE:GL) stock price decreased by 15.65% to $88.51, exhibiting a 18.68% gap. |
| LOVE | -14.81% | Today, LOVESAC CO/THE's (NASDAQ:LOVE) stock experienced a 14.81% fall to $19.88 with a 19.13% gap. yesterday the company released their earnings. In the last 6 months the stock gained 39.26%. |
| FFIEW | -13.33% | In today's session, FARADAY FUTURE -CW27's (NASDAQ:FFIEW) stock price decreased by 13.33% to $0.01, exhibiting a 16.13% gap. In the last month the stock gained 32.74%. |
| ROOT | -12.5% | In today's session, ROOT INC/OH -CLASS A's (NASDAQ:ROOT) stock price decreased by 12.5% to $67.26, exhibiting a 20.39% gap. A press release (Root, Inc. Schedules Conference Call to Discuss First Quarter 2024 Financial Results) was released yesterday. |
| KMX | -12.28% | CARMAX INC's (NYSE:KMX) shares experienced a 12.28% decline to $69.56 during Thursday's session, accompanied by a 14.4% gap. The company's earnings where released Yesterday. A press release (CarMax Reports Fourth Quarter and Fiscal Year 2024 Results) was released earlier today. |
To see the full list of gap down stocks you can use our gap down stocks screener.
ENLIVEN THERAPEUTICS INC
NASDAQ:ELVN (4/29/2024, 7:00:01 PM)
After market: 17.65 -0.14 (-0.79%)17.79
+0.61 (+3.55%)
ELVN News
4 days ago - Market News VideoCommit To Purchase Enliven Therapeutics At $10, Earn 11.2% Annualized Using Options
19 days ago - ChartmillThe market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.Thursday's session: gap up and gap down stocks
Achieved initial cumulative MMR rate of 44% (7/16) by 12 weeks in response-evaluable patients, which compares favorably to precedent Phase 1 trials of...
BOULDER, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precision...
BOULDER, Colo., March 28, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage precision...
Financing includes participation from new and existing investors Net proceeds, along with existing cash, cash equivalents and marketable securities, are...
2 months ago - InvestorPlaceELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q4 2023ELVN stock results show that Enliven Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
2 months ago - BusinessInsiderELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Enliven Therapeutics (NASDAQ:ELVN) just reported results for the fourth quarter...
Initial proof of concept data from Phase 1a trial evaluating ELVN-001 in adults with chronic myeloid leukemia (CML) is expected in the second quarter of 2024
BOULDER, Colo., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Enliven Therapeutics, Inc. (Enliven) (Nasdaq: ELVN), a clinical-stage precision oncology focused on the...
3 months ago - Market News VideoCommit To Purchase Enliven Therapeutics At $15, Earn 18.4% Annualized Using Options
